REJO Unveils New Brand Concept and European Market Expansion Strategy
5.4.2025 07:29:00 CEST | Business Wire | Press Release
REJO, a global provider of heat-not-burn(HNB) solutions, proudly unveils its refreshed brand identity and strategic expansion into the European market, which is a meaningful milestone in its journey of growth and innovation. Known for crafting innovative and reliable products, REJO’s new visual identity reflects its progressive approach to advancing the industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250404882478/en/
Crowds Gathering at the REJO Stand
Strategic Market Entry into Europe
Building on its steady progress in Southeast Asia and the Middle East, REJO is now poised to tackle the challenges of the European market with a focus on Switzerland and the Czech Republic with its diverse product range and market adaptability. Recognizing the rising demand for herbal alternatives, REJO is making thoughtful investments in heat-not-burn products, including TOZE herbal sticks, inspired by East Asia’s rich tradition of tea-based cigarettes.
Designed to deliver a refined user experience, TOZE herbal sticks pair seamlessly with REJO HS40, the company’s signature heating device, ensuring optimal flavor and consistency. This tailored approach positions REJO as a reliable provider of innovative alternatives in European HNB market.
A Fresh Look for a New Chapter
“Take a Break. Take REJO.”
With a renewed vision, REJO unveils a refreshed brand identity alongside a new slogan that underscores its commitment to offering innovative alternatives to traditional smoking. The brand now features a vibrant color palette, centered around a warm, inviting shade of green-symbolizing comfort, relaxation and a natural connection to the essence of the product.
The redesigned brand icon, featuring an extended “O” with a petal-like shape, highlights REJO’s advanced heating technology and reflects the brand’s commitment to innovation. This change aligns with REJO’s mission to empower individuals with mindful alternatives that redefine the smoking experience, while embracing the smoke-free future alongside its global partners.
REJO aims to be a trusted companion during those brief five-minute pauses in life, offering a diverse range of alternatives that support the journey toward a mindful lifestyle. Through ongoing innovation, REJO is driving change and inspiring an elevated way of living for consumers around the world.
Commitment to Innovation
The TOZE brand name embodies REJO’s commitment to join a smoke-free future, symbolizing the combination of “TO-bacco ZE-ro”.
Leveraging the well-established expertise in tea-based cigarettes from East Asia, REJO has innovated a unique herbal stick formulation that combines natural tea fibers, nicotine, and precisely balanced flavors. After over 300 product trials, REJO has perfected a formula that enhances aroma absorption while delivering a rich, full-bodied experience with every use.
Paired with the REJO HS40 heating device-boasting an impressive 40-stick capacity per charge-this combination delivers a smoother, more consistent flavor profile.
Strengthening Market Presence in Europe
REJO is strengthening its foothold in Europe, starting with the Czech Republic and Switzerland. Following a recently signed Memorandum of Understanding (MOU) with a Czech distributor, REJO is poised to further expand TOZE’s footprint across the region. This initiative is part of a broader market strategy to establish a strong European presence.
Early market feedback from France, particularly among traditional tobacco retailers, has underscored the growing demand for TOZE products. Praised for their consistent aroma and reduced smoke odor, TOZE herbal sticks are well-positioned to meet the rising market demand for flavored alternatives.
Localized Growth and Consumer Engagement
REJO’s European expansion goes beyond product availability-it’s about building lasting connections with consumers. The company is actively recruiting industry professionals who embody its brand spirits:
“Stay Courageous, Be Undefined.”
To ensure a seamless market entry, REJO has secured key regulatory approvals, including: Tobacco Products Directive (TPD) registration, Poison Centre Notification (PCN) compliance, and Track-and-Trace registration.
Additionally, REJO is launching the REJO Club Fans Community, blending online interactions with offline events to create meaningful brand experiences and foster deeper connections with local users. By redefining the traditional five-minute break, REJO seeks to engage consumers through interactive experiences that go beyond product use, exploring new possibilities while meeting consumer needs.
Global Expansion and Continued Growth
While Europe remains a key focus, REJO continues to expand its global footprint, with products now available in nearly 10,000 retail outlets across Russia, the Middle East, and Southeast Asia. With a diversified product portfolio and the flexibility to adapt to various markets, REJO is poised for continued growth.
In Southeast Asia, REJO has rapidly expanded its presence, securing distribution in convenience stores and lifestyle locations. In Indonesia, the brand has established brand booths in cafés and dining bars, integrating e-commerce solutions for greater accessibility.
In the Middle East, REJO has solidified its presence through an exclusive partnership agreement at World Tobacco Dubai 2024 and a major distributor event in Dubai, engaging over 20 secondary distributors.
These efforts reflect REJO’s commitment to scalable, sustainable growth in key markets worldwide.
Pioneering the Future of Heat-Not-Burn Solutions
As REJO continues its global expansion, the company remains committed to its mission of redefining the smoking experience through innovation, reliability, and sustainability. With a strong foundation in place and ambitious plans for growth in Europe and beyond, REJO is committed to delivering reliable alternatives that empower consumers to make informed choices about their smoking experience.
“We remain flexibility in adapting to the changing market. By integrating market insights with technological advancements, we are confident that our European expansion will strengthen our position within the HNB industry,” said Li. “We believe in the potential of this market and are dedicated to creating reliable, accessible alternatives that cater to the evolving needs of global consumers.”
About REJO
REJO is a pioneering global provider in heat-not-burn solutions, crafting innovative and reliable products that redefine the smoking experience.
In partnership with REJO Friends, we are committed to delivering exceptional user experiences worldwide. Our diverse product portfolio champions healthier alternatives, setting a new standard for mindful consumption.
For more information about REJO and its products, visit www.rejonow.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250404882478/en/
Contacts
Newsroom@rejonow.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom